1. Eye drops for the treatment of macular edema, containing difluprednate as the active ingredient. 2. Eye drops according to claim 1, wherein the macular edema is refractory macular edema. Eye drops according to claim 1 or 2, which are eye drops in the form of an emulsion. Eye drops according to claim 1, wherein the concentration of difluprednate is 0.005-0.1% (m / v). Eye drops according to claim 1, containing 0.005-0.1% (m / v) difluprednata and castor oil, polysorbate 80, concentrated glycerin, sodium acetate, boric acid, sodium edetate and sorbic acid. The eye drops of claim 1, wherein the concentration of difluprednate is 0.005-0.1% (m / v), the dosing period is at least 1 week, the frequency of administration is 4 times a day, and the dose is 30-50 μl per introduction. 7. The eye drops of claim 1, wherein the concentration of difluprednate is 0.005-0.1% (m / v), the dosing period is 1-4 weeks, the frequency of administration is 4 times per day, and the dose is 30-50 μl per administration. . Eye drops according to claim 1, where the concentration of difluprednate is 0.005-0.1% (m / v), the frequency of administration is 4 times a day for 4 weeks from the start of administration and twice a day after 4 weeks, and the dose is 30- 50 μl per administration. 9. Eye drops according to claim 1, where the concentration of difluprednate is 0.005-0.1% (m / v), the dosing period is no more than 12 weeks, the frequency of administration is 4 times a day for 4 weeks from the start of administration and twice a day after 4 weeks, and the dose is 30-50 μl per administration. 10. Eye drops according to claim 1, where the concentration of difluprednate is 0.005-0.1% (m / v), the dosage period is at least 12 weeks, the frequency of administration is 4 times per day1. Глазные капли для лечения отека желтого пятна, содержащие дифлупреднат в качестве активного ингредиента.2. Глазные капли по п.1, где отек желтого пятна представляет собой рефракторный отек желтого пятна.3. Глазные
